Preferred Label : Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy;
CISMeF acronym : DOA ;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Dominant optic atrophy plus syndrome; DOA ;
Description : Syndromic optic atrophy, also known as DOA syndrome, is a neurologic disorder characterized
most commonly by an insidious onset of visual loss and sensorineural hearing loss
in childhood with variable presentation of other clinical manifestations including
progressive external ophthalmoplegia (PEO), muscle cramps, hyperreflexia, and ataxia.
There appears to be a wide range of intermediate phenotypes (Yu-Wai-Man et al., 2010).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the OPA1 mitochondrial dynamin-like GTPase gene (OPA1, 605290.0011);
Prefixed ID : #125250;
Origin ID : 125250;
UMLS CUI : C3276549;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)